Vaccine prevents cancer relapse

An experimental off-the-shelf vaccine shows promise in preventing the return of pancreatic and colorectal cancers. The vaccine targets common mutations in the Kras gene, training the immune system to identify and eliminate cancer cells. Early results suggest patients with a strong immune response had a lower risk of relapse and longer survival. This non-personalized approach could offer a cheaper and faster alternative to current therapies, though larger, controlled trials are needed to confirm its efficacy and safety.